Blastic Plasmacytoid Dendritic Cell Neoplasm Following Acquired Erythropoietic Protoporphyria

References

• Lindsey K, Burch M, Krause JR. A case of erythropoietic protoporphyria. Proc (Bayl Univ Med Cent) 2016;29 (3):311–312.
   PubMedGoogle Scholar
• Chaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F, Orfeuvre H, Corront B, Feuillard J, Sotto JJ, Bensa JC, Briere F, Plumas J, Jacob MC. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001;97 (10):3210–3217.
   PubMed Web of Science ®Google Scholar
• Petrella T, Comeau MR, Maynadié M, Couillault G, De Muret A, Maliszewski CR, Dalac S, Durlach A, Galibert L. Agranular CD4+, CD56+ hematodermic neoplasm (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002;26 (7):852–862.
   PubMed Web of Science ®Google Scholar
• Marafioti T, Paterson JC, Ballabio E, Reichard KK, Tedoldi S, Hollowood K, Dictor M, Hansmann ML, Pileri SA, Dyer MJ, Sozzani S, Dikic I, Shaw AS, Petrella T, Stein H, Isaacson PG, Facchetti F, Mason DY. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 2008;111 (7):3778–3792.
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127 (20):2391–2405.
   PubMed Web of Science ®Google Scholar
• Feuillard J, Jacob MC, Valensi F, Maynadie M, Gressin R, Chaperot L, Arnoulet C, Brignole-Baudouin F, Drenou B, Duchayne E, Falkenrodt A, Garand R, Homolle E, Husson B, Kuhlein E, Le Calves G, Sainty D, Sotto MF, Timoreau F, Bene MC. Clinical and biologic features of CD4+, CD56+ malignancies. Blood 2002;99 (5):1556–1563.
   PubMed Web of Science ®Google Scholar
• Julia F, Dalle S, Duru G, Balme B, Vergier B, Ortonne N, Vignon-Pennamen MD, Costes-Martineau V, Lamant L, Dalac S, Dellattre C, Dechelotte P, Courville P, Carlotti A, De Muret A, Fraitag S, Levy A, Mitchell A, Petrella T. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients. Am J Surg Pathol 2014;38 (5):673–680.
   PubMed Web of Science ®Google Scholar
• Alayed K, Patel KP, Konoplev S, Singh RR, Routbort MJ, Reddy N, Pemmaraju N, Zhang L, Shaikj AA, Aladily TN, Jain N, Luthra R, Medeiros LJ, Khoury JD. TET 2 mutations, myelodysplastic features and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow. Am J Hematol 2013;88 (12):1055–1061.
   PubMed Web of Science ®Google Scholar
• Leroux D, Mugneret F, Callanan M, Radford-Weiss I, Dastugue N, Feuillard J, Le Mee F, Plessis G. Talmant P, Gachard N, Uettwiller F, Pages MP, Mozzoconacci MJ, Eclache V, Sibille C, Avet-Loiseau H, Lafage-Pochitaloff M. CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood 2002;99 (11):4154–4159.
   PubMed Web of Science ®Google Scholar
• Sapienza MR, Fuligni F, Agostinelli C, Tripodo C, Righi S, Laginestra MA, Pileri A Jr, Mancini M, Rossi M, Ricci F, Gazzola A, Melle F, Mannu C, Ulbar F, Arpinati M, Paulli M, Maeda T, Gibellini D, Pagano L, Pimpinelli N, Santucci M, Cerroni L, Croce CM, Facchetti F, Piccaluga PP, Pileri SA; AIRC 5xMille Consortium Genetics-Driven Targeted Management of Lymphoid Malignancies and the Italian Registry on Blastic Plasmacytoid Dendritic Cell Neoplasm. Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition. Leukemia 2014;28 (8):1606–1616.
   PubMed Web of Science ®Google Scholar
• Piccaluga PP, Paolini S, Sapienza MR, Pileri SA. Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care. Expert Rev Hematol 2012;5 (4):353–355.
   PubMed Web of Science ®Google Scholar
• Roos-Weil D, Dietrich S, Boumendi A, Polge E, Bron D, Carreras E, Iriondo A, Arcese W, Beelen DW, Cornelissen JJ, Kroger NS, Milone G, Rossi G, Jardin F, Peters C, Rocha V, Sureda A, Mohty M, Dreger P; European Group for Blood and Marrow Transplantation Lymphoma, Pediatric Diseases, and Acute Leukemia Working Parties. Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood 2013;121 (3):440–446.
   PubMed Web of Science ®Google Scholar
• Unteregger M, Valentin A, Zinke-Cerwenka W, Troppan K, Deutsch A, Cerroni L, Linkesch W, Neumeister P. Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm. Bone Marrow Transplant 2013;48 (6):799–802.
   Web of Science ®Google Scholar